Regen BioPharma Inc (RGBP)

[Jaguarjacket]

During the coming months I shall endeavor to achieve the following milestones:

1) Settle all outstanding convertible notes payable in order that the Company will have no convertible instruments outstanding.
2) Hire a Chief Scientific Officer
3) Seek out and enter into alliances, co-development agreements and additional licensing agreements with regard to our proprietary mRNA and NR2F6 portfolios.
4) Obtain OTCQB listing for our securities on the OTC Market.
5) Establish a social media presence in order to more easily provide updates to our shareholders, the investment community, the scientific community and the public at large.


Thank you for your past and continued patience as we move the Company forward. I look forward to receiving shareholder input and can be reached at [e-mail].

Sincerely,

David Koos